Treatment for SUI
Stress Urinary Incontinence Spectrum
Injectable products have an important role to play within the SUI treatment offerings. However, current UBAs are mostly a last resort treatment option for women unable or unwilling to undergo a surgical procedure, or after a failed surgical intervention. Urolon now represents a new opportunity for these women. Urolon has the potential to address a much wider population of women suffering with SUI; especially those who currently do not come forward for treatment, opting to try to manage their condition alone, or prefer not to have a non-resorbable, permanent implant.